BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32651045)

  • 1. Case for diagnosis. Infiltrated areas on the trunk.
    Góes LDM; Scrignoli JA; Morais P; Talhari C
    An Bras Dermatol; 2020; 95(5):652-654. PubMed ID: 32651045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 4. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 7. Case for diagnosis. Erythematous and infiltrated plaques in the infrahyoid region.
    Bezerra NTC; Schettini APM; Leturiondo AL; Mathias LHMT
    An Bras Dermatol; 2021; 96(1):97-99. PubMed ID: 33288364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
    Wabitsch KR; Meyers WM
    Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium leprae and Mycobacterium lepromatosis Infection: a Report of Six Multibacillary Cases of Leprosy in the Dominican Republic.
    Fernández JDP; Pou-Soarez VE; Arenas R; Juárez-Duran ER; Luna-Rojas SL; Xicohtencatl-Cortes J; Martínez-Chavarría LC; Martínez-Hernández F; Hernández-Castro R
    Jpn J Infect Dis; 2022 Jul; 75(4):427-430. PubMed ID: 35354704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
    Gelber RH; Balagon VF; Cellona RV
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sub-polar lepromatous leprosy localized to the face.
    George M; Rajan U; George S; Pakran J; Thomas S
    Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant cells lepromatous leprosy. Diffuse dermatitis with exuberant foreign body giant cells in treated lepromatous leprosy.
    Rodríguez G; Arias V
    Biomedica; 2019 Aug; 39(Supl. 2):26-31. PubMed ID: 31529831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy - an overview of clinical features, diagnosis, and treatment.
    Fischer M
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):801-827. PubMed ID: 28763601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case study in Hansen's disease acquired after heart transplant.
    Launius BK; Brown PA; Cush E; Mancini MC
    Crit Care Nurs Q; 2004; 27(1):87-91. PubMed ID: 14974527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy.
    Zaheer SA; Mukherjee R; Ramkumar B; Misra RS; Sharma AK; Kar HK; Kaur H; Nair S; Mukherjee A; Talwar GP
    J Infect Dis; 1993 Feb; 167(2):401-10. PubMed ID: 8421173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS; Bhanage ND; Sawant KV; Ganapati R
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.